home
Efficiency  
How to use Veinoplus  
Order  
 
distributor Area  
 
 
 
  • VEINOPLUS® V.I. is a medical electro-stimulation device with therapeutic effects upon various symptoms of Venous Insufficiency. These effects have been demonstrated and documented in several clinical studies  made since 2004 in France, UK, USA and Russia

  • Over 100 000 people with venous problems in 25 countries have already chosen the technology VEINOPLUS® V.I.
Clinically proven efficacy
 
 
     
 
*When in doubt, consult your doctor. The effects are not guaranteed and may vary depending on the symptoms and people. Contraindications and precautions: see Instruction Manual.
 
 
Your New Treatment for
  Venous Disease
 
 
 
Reduce il gonfiore delle gambe (edema)*-
Back
 
 
  • Epidemiology
    Edema of the lower limbs is one of the leading symptoms of Venous Insufficiency (VI). A Study conducted in more than 3 000 subjects, population-based cross-sectional study (The Bonn Vein Study), 13.4% of the population had manifest leg edema (1).

  • Pathology
    Defined as an increase in the volume of interstitial fluid, edema is the sign of an anomaly of transcapillary fluid movement (2).
    VI mostly brings on a sporadic edema, enhanced by prolonged orthostatic posture, heat and excess weight (2). Venous edema can be unilateral or bilateral.
    Stimulation of the calf muscle pump prevents the formation of venous edema by reducing the venous pressure in legs (3).

  • Factors of risk
    • Previous history of venous disease in the family
    • Prolonged orthostatic posture
    • Heat
    • Excess weight
    • Pregnancy
    • Post-Thrombotic Syndrome
 
 
  • VEINOPLUS® Action
    • Reduction of the edema circumference or even disappearance of the edema
    • Rapid reduction of PAIN in legs
    • Improvement in Quality of Life
    • Can be used in combination with compression therapy
    • VEINOPLUS® can be used by pregnant women
 
 
 
  • Clinical Data of VEINOPLUS®
    • A clinical study conducted by the Pr Bogachev (State University of Moscow) on 30 patients (32 legs) has proven the efficiency of VEINOPLUS in venous edema .
    • A clinical study conducted by the Dr Le Tohic (Hospital Bichat) on 58 pregnant women has demonstrated the effects of VEINOPLUS® in edemas (4).
    • A study made in 100 users in France underlined the action of VEINOPLUS® in the treatment of edema.
 
 
 
  • Instruction for use
    Apply an electrode on to each calf if the pain sensation is bilateral and both electrodes on the same calf if the pain sensation is unilateral. Do at least one session if painful sensations exist preferably in seated position.
    Setting of the device should be performed according to the patient tolerance.
 
  1. Maurins U, Hoffmann B, Lösch C. Distribution and prevalence of reflux in the superficial and deep venous system in the general population _ results from the Bonn Vein Study, Germany..Journal of Vascular Surgery, Volume 48, Issue 3, September 2008
2. VALMI Edition 2010-2011
3. Stick C, Grau H, Witzleb E. On the edema-preventing effect of the calf muscle pump ;Eur J Apll Physiol (1989) 59 :39-47
4. Le Tohic A, Bastian H, Pujo M,. Madelinot P.Effets de l’électrostimulation par VEINOPLUS® sur les troubles circulatoires des membres inférieurs chez la femme enceinte. Gynecol Obstet&Fertil 2009 ; 37 :18-24
 
 
Reduces pain in legs*  |   Helps for restless legs and night cramps*  |   Can be used during pregnancy  |  
 
 
 
 
 
  Testimonies
By Mrs Sylvie D.
Hi, I have been using the small device for a few years now and I very ...
  Clinical Data
Electrostimulation with Veinoplus® for the Treatment of Chronic Venous Edema
  News - Events
     
OT WORLD - Leipzig Hall 1, stand D30 : 06-11-2013
 
 
     
Contact  |  Electrodes  |  FAQ  |  After sales service & warranty  |  Sitemap  |  Legal notice  |  Sales conditions         
 
© Copyright 2012 Paris - Ad Rem Technology

*When in doubt, consult your doctor. The effects are not guaranteed and may vary depending on the symptoms and people. Contraindications and precautions: see Instruction Manual.